Development of a liquid chromatography–mass spectrometry based targeted metabolomics method for discovering diagnostic biomarkers in Kawasaki disease
Journal of Chromatography A · 2025
DOI: 10.1016/j.chroma.2024.465619 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Chromatography A, 2025. Verfasst von Xialin Luo und 7 weiteren Autor:innen. Beteiligte Einrichtung: Shanghai Center for Clinical Laboratory, Shanghai, PR China. Hauptthemen laut MEDLINE: Mucocutaneous Lymph Node Syndrome, Biomarkers, Metabolomics, Mass Spectrometry. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 33 Literaturangaben. Gefördert von: Science and Technology Commission of Shanghai Municipality, Natural Science Foundation of Jiangsu Province.
Abstract (Originalsprache)
Kawasaki disease (KD) has emerged as the leading cause of acquired heart disease in children, primarily due to the absence of highly sensitive and specific biomarkers for early and accurate diagnosis. To address this issue, a simple and comprehensive targeted metabolomics method employing ultra high-performance liquid chromatography coupled with Q-TRAP mass spectrometry has been developed to identify new metabolite biomarkers for KD. This method enables the simultaneous quantification of 276 metabolites, covering 60 metabolic pathways, with a particular emphasis on metabolites relevant to KD. The use of nine ISs and commercial quality control samples significantly enhances both accuracy and precision. Through validation and application to serum samples from patients with KD, seventeen differential serum metabolites were identified. The altered metabolites are primarily associated with three functional metabolic pathways: tricarboxylic acid cycle, tryptophan metabolism, and bile acid metabolism, all of which are believed to be involved in the inflammatory and immune responses in KD patients. Ultimately, eight differential metabolites (indole-3-propionic acid, thiamine, indolepyruvic acid, levodopa, l-selenomethionine, isocitric acid, trans-aconitate, and N-acetylasparagine) were identified that could potentially serve as diagnostic biomarkers with the area under the curve values exceeding 0.9. Our targeted metabolomics approach demonstrates applicability in identifying potential metabolite biomarkers for KD and holds great promise in unraveling the intricate pathophysiology of the disease.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Shanghai Center for Clinical Laboratory, Shanghai, PR China.
- School of Medical Informatics and Engineering, Xuzhou Medical University, Xuzhou, Jiangsu Province, PR China.
- Department of Clinical Laboratory, Shanghai Children's Hospital, School of Medicine, Shanghai Jiao Tong University, Shanghai, PR China; Institute of Pediatric Infection, Immunity, and Critical Care Medicine, School of M…
- School of Chinese Medicine, Hong Kong Traditional Chinese Medicine Phenome Research Center, State Key Laboratory of Environmental and Biological Analysis, Hong Kong Baptist University, Hong Kong, PR China. Electronic ad…
- Shanghai Center for Clinical Laboratory, Shanghai, PR China. Electronic address: juyi@sccl.org.cn.
Förderung
- Science and Technology Commission of Shanghai Municipality
- Natural Science Foundation of Jiangsu Province
Zitieren
APA
Luo, X., Tian, J., Li, Q., Jin, Z., Fan, X., Zhang, H., Lv, H., & Ju, Y. (2025). Development of a liquid chromatography–mass spectrometry based targeted metabolomics method for discovering diagnostic biomarkers in Kawasaki disease. Journal of Chromatography A. https://doi.org/10.1016/j.chroma.2024.465619
Vancouver
Luo X, Tian J, Li Q, Jin Z, Fan X, Zhang H, et al. Development of a liquid chromatography–mass spectrometry based targeted metabolomics method for discovering diagnostic biomarkers in Kawasaki disease. Journal of Chromatography A. 2025. doi:10.1016/j.chroma.2024.465619
BibTeX
@article{Luo2025,
author = {Luo, Xialin and Tian, Jiaqi and Li, Qing and Jin, Zhonggan and Fan, Xiaoyu and Zhang, Hong and Lv, Haitao and Ju, Yi},
title = {Development of a liquid chromatography–mass spectrometry based targeted metabolomics method for discovering diagnostic biomarkers in Kawasaki disease},
journal = {Journal of Chromatography A},
year = {2025},
doi = {10.1016/j.chroma.2024.465619}
}
EUVIMED